4.6 Article

A very humiliating illness: a qualitative study of patient-centered Care for Rifampicin-Resistant Tuberculosis in South Africa

Journal

BMC PUBLIC HEALTH
Volume 20, Issue 1, Pages -

Publisher

BMC
DOI: 10.1186/s12889-019-8035-z

Keywords

South Africa; Costs; Challenges; Social support; Counseling

Funding

  1. Health Systems Research Initiative award from the Medical Research Council of the United Kingdom
  2. Wellcome Trust [MR/N015924/1]
  3. European Union
  4. Wellcome Trust fellowship award [099818]
  5. South African Medical Research Council
  6. United Way Worldwide grant by the Lilly Foundation on behalf of the of the Lilly MDR-TB Partnership
  7. MRC [MR/N015924/1] Funding Source: UKRI

Ask authors/readers for more resources

Background Patient-centered care is pillar 1 of the End TB strategy, but little has been documented in the literature about what this means for people living with rifampicin-resistant (RR-TB). Optimizing care for such individuals requires a better understanding of the challenges they face and the support they need. Methods A qualitative study was done among persons living with RR-TB and members of their support network. A purposive sample was selected from a larger study population and open-ended interviews were conducted using a semi-standard interview guide. Interviews were recorded and transcribed and the content analyzed using an iterative thematic analysis based in grounded theory. Results 16 participants were interviewed from three different provinces. Four distinct periods in which support was needed were identified: 1) pre-diagnosis; 2) pre-treatment; 3) treatment; and 4) post-treatment. Challenges common in all four periods included: socioeconomic issues, centralized care, and the need for better counseling at multiple levels. Conclusions Beyond being a very humiliating illness, RR-TB robs people of their physical, social, economic, psychological, and emotional well-being far beyond the period when treatment is being administered. Efforts to tackle these issues are as important as new drugs and diagnostics in the fight against TB.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available